Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding
- 1 December 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 150 (2) , 136-138
- https://doi.org/10.1007/bf02072057
Abstract
We report a 3-week-old boy with cholestatic hepatitis, most likely due to carbamazepine exposure during pregnancy and breastfeeding. Cholestasis resolved after cessation of nursing. Liver function test results and histological findings were compatible with a drug-induced hepatitis. Other causes were excluded. While carbamazepine-induced hepatitis is well known in children and adults, it has never been described in association with prenatal exposure and/or breast-feeding.This publication has 13 references indexed in Scilit:
- American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk.1989
- A case of hepatitis associated with carbamazepine therapyEuropean Journal of Pediatrics, 1988
- Carbamazepine Side Effects in Children and AdultsEpilepsia, 1987
- Acute hepatitis in a patient treated with carbamazepineZeitschrift für Neurologie, 1985
- [Acute cholestatic hepatitis due to carbamazepine].1984
- [Acute hepatitis due to carbamazepine (Tegretol). Study of a case and review of the literature].1984
- Granulomatous hepatitis associated with carbamazepine therapyThe American Journal of Medicine, 1981
- Granulomatous Hepatitis Secondary to CarbamazepineAnnals of Internal Medicine, 1981
- Fatal carbamazepine hepatitisThe Journal of Pediatrics, 1977